1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Argentina Pharmaceuticals and Healthcare Report Q1 2016

Argentina Pharmaceuticals and Healthcare Report Q1 2016

  • November 2015
  • -
  • Business Monitor International
  • -
  • 110 pages

Includes 3 FREE quarterly updates

BMI View: Robust pharmaceutical and healthcare market growth in Argentina will lead to improvedopportunities for drugmakers over the next 10 years. Despite the government's increased focus on domesticpharmaceutical production, Argentina will retain its negative pharmaceutical trade balance and relianceon foreign patented drugs. Rising demand and healthcare costs will continue to translate to a pattern ofregulatory mechanisms to allow for multiple payers to jointly negotiate prices for the bulk purchasing ofdrugs, both at the regional level under MERCOSUR structures and at the national level throughArgentinean health coverage subsystems. Meanwhile, the increased attention on regulatory standardimprovements, such as the recent creation of a biological medicines centre, as well as a skilled workforce,will contribute in fostering investor interest in Argentina.Headline Expenditure ProjectionsPharmaceuticals: ARS54.93bn (USD6.76bn) in 2014 to ARS64.46bn (USD7.12bn) in 2015; +17.3% inlocal currency terms and 5.3% in US dollar terms. Forecast revised upwards from last quarter.Healthcare: ARS258.63bn (USD31.84bn) in 2014 to ARS277.19bn (USD30.63bn) in 2015; +7.2% in localcurrency terms and -3.8% in US dollar terms. Forecast broadly in line with last quarter.

Table Of Contents

Argentina Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Argentina 2013-2019) 7
SWOT 10
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Argentina 2011-2019) 15
Healthcare Market Forecast 16
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2011-2019) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2011-2019) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2011-2019) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Argentina 2011-2019) 22
Patented Drug Market Forecast 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Argentina 2011-2019) 26
Generic Drug Market Forecast 27
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Argentina 2011-2019) 29
OTC Medicines Forecast 30
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Argentina 2011-2019) 32
Pharmaceutical Trade Forecast 33
Table: Pharmaceutical Trade Data And Forecasts (Argentina 2013-2019) 35
Table: Pharmaceutical Trade Data And Forecasts local currency (Argentina 2013-2019) 36
Industry Risk Reward Index 37
Americas Risk/Reward Index 37
Argentina Risk/Reward Index 44
Rewards 44
Risks 45
Regulatory Review 46
Table: Product Registration, Annex I and II Listed Countries 47
Intellectual Property Environment 53
Pricing Regime 57
Table: Pharmaceutical Price Build-Up 59
Reimbursement Regime 60
Other Regulatory Issues 60
Market Overview 63
Healthcare Sector 64
Healthcare Insurance 64
Medical Tourism 66
Table: Healthcare Resources (Argentina 2009-2014) 67
Table: Healthcare Personnel (Argentina 2009-2014) 67
Table: Healthcare Activity (Argentina 2009-2014) 68
Research and Development 68
Clinical Trials 71
Epidemiology 72
Competitive Landscape 75
Research Based Industry 76
Table: Table: Multinational Market Activity 79
Generic Drugmakers 80
Pharmaceutical Distribution 82
Pharmaceutical Retail Sector 82
Company Profile 86
GlaxoSmithKline 86
Laboratorios Bago 89
Novartis 93
Sanofi 96
Demographic Forecast 99
Table: Population Headline Indicators (Argentina 1990-2025) 100
Table: Key Population Ratios (Argentina 1990-2025) 100
Table: Urban/Rural Population and Life Expectancy (Argentina 1990-2025) 101
Table: Population By Age Group (Argentina 1990-2025) 101
Table: Population By Age Group % (Argentina 1990-2025) 102
Glossary 104
Methodology 106
Pharmaceutical Expenditure Forecast Model 106
Healthcare Expenditure Forecast Model 106
Notes On Methodology 107
Risk/Reward Index Methodology 108
Index Overview 109
Table: Pharmaceutical Risk/Reward Index Indicators 109
Indicator Weightings 110

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.